[1]
Goldenberg, L. et al. 2013. The role of 5-alpha reductase inhibitors in prostate pathophysiology: Is there an additional advantage to inhibition of type 1 isoenzyme?. Canadian Urological Association Journal. 3, 3-S2 (May 2013), S109-S114. DOI:https://doi.org/10.5489/cuaj.1114.